DOCSLIB.ORG

Neurotransmitter Balance: the Key to Understanding Addiction

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Neurotransmitter Balance: the Key to Understanding Addiction Howdy! Neurotransmitter Balance: The Key to Understanding Addiction Jeff Sandoz, PhD Troy University Acknowledgements • Special thanks go to Dr. Fred Von Stieff for permission to use his diagram in this presentation from his book Brain In Balance. • With gratitude for Dr. Daniel Inaba and CNS Productions Inc. for the use of the information on slides courtesy of CNS Productions, Medford Oregon via their publication Uppers, Downers, All Arounders. Outline - Neurotransmitter Balance I. Book Brain In Balance II. Neurotransmitter System III. GABA vs Glutamate IV. Brain Scans & the Future Book I IV Brain Scans & the Future III VS. II Mind Map Neurotransmitter Visual Systems I. Book Rosetta Stone: Understand the 3 Factor Relationship among Drug Use, Craving & Neurotransmitters levels. About the Author •Board-certified Addictionologist •Over 20,000 successful detoxified patients [Evidence-Based Best Practice] •Medical Director three chemical dependency programs •Certified-American Board of Addiction Medicine •Certified-American Society of Addiction Medicine •Certified-California Society of Addiction Medicine •Chief Medical Review Officer-State of California Dr. Von Stieff •Legal expert in substance abuse II. Neurotransmitter Systems Goal: Learn the rules of HOW THE BRAIN WORKS, making sense of how the neurotransmitters function. Analogy: Putting together pieces of the Brain Puzzle Build a puzzle: Start on the borders & work your way in. Glutamate Acetylcholine Endocannabinoid GABA Serotonin Dopamine Premise: Brain is Seeking Balance Most healthcare professionals do not understand how addiction and detoxification affect neurochemical systems of patients. Dynamic State of Equilibrium Neurotransmitter Diagram Purpose: Understand brain imbalance related to addiction – Done by viewing neurotransmitter levels of patient. 8 Neurotransmitters Add 7 colors of the rainbow and white to enhance your memory of the location of each neurotransmitter. [ROY G BIV] 8 Basic Neurotransmitter Systems Visualizing this diagram helps to understand what is going on in the person’s brain. Specifically how neurochemical balance can be altered. Diagram: Placing the Neurotransmitters • Large circle represents patient’s brain. • 8 smaller circles represent eight neurotransmitter systems. Diagram: Placing the Neurotransmitters • Resembling the chambers of a six shooter • + one more • & one in the middle. Diagram: Placing the Neurotransmitters • Resembling the face of a clock: • Opiates in the middle. Diagram: Placing the Neurotransmitters • Resembling the face of a clock: • Serotonin at 1 o’clock Diagram: Placing the Neurotransmitters • Resembling the face of a clock: • GABA between 2 and 3 o’clock Diagram: Placing the Neurotransmitters • Resembling the face of a clock: • Glutamate between 4 and 5 o’clock Diagram: Placing the Neurotransmitters • Resembling the face of a clock: • Dopamine at 6 o’clock Diagram: Placing the Neurotransmitters • Resembling the face of a clock: • Noradrenaline between 7 and 8 o’clock Diagram: Placing the Neurotransmitters • Resembling the face of a clock: • Acetylcholine between 9 and 10 o’clock Diagram: Placing the Neurotransmitters • Resembling the face of a clock: • Endocannabinoid at 11 o’clock Visualizing the Neurotransmitter System Utilize Diagram 4 Times 1) Genetic Deficiencies Imbalance due to Mental Illness, Trauma, Stress Visualizing the Neurotransmitter System Utilize Diagram 4 Times 1) Genetic Deficiencies Imbalance/MI/Trauma 2) Effect of Self- Medicating Drugs Visualizing the Neurotransmitter System Utilize Diagram 4 Times 1) Genetic Deficiencies Imbalance/MI/Trauma 2) Effect of Self- Medicating Drugs 3) Withdrawal & Detox Visualizing the Neurotransmitter System Utilize Diagram 4 Times 1) Genetic Deficiencies Imbalance/MI/Trauma 2) Effect of Self- Medicating Drugs 3) Withdrawal & Detox 4) Stabilization:Add Meds to Correct or Balance the System Address & Analyze Patient Neurochemical Imbalance 1 Genetic Deficiencies, Predispositions in Family -Stress/Mental Illness, Trauma Sources –Psychosocial History, Genogram, Family Drinking Survey. Helpful information with regard to genetic issues – neurotransmitter deficiencies and imbalances. Diagram 1 – Showing the Genetic Ailment • Disposition –Mental status/ emotional mood • Background – Family members DSM-V Neurotransmitter X • Cravings –Past/Present Drug Use Acetylcholine • Sketch diagram/X marks Endocannabanoid neurotransmitter Serotonin • Review notes on possible GABA neurotransmitters out of balance. Glutamate Review research on pubmed.com. Dopamine Noradrenaline Opiate Diagram 1 – Showing the Genetic Ailment • Genetic Predispositions in Family Condition X Alcoholism Bipolar Anxiety Depression X Schizophrenia Drug Addiction Eating Disorders PTSD Other Diagram 1 – Showing the Genetic Ailment • Example - Cocaine Addiction & Depression • Drug of Choice Cocaine. Review research on pubmed.com. • Family Conditions DSM-V Parental Alcohol Addiction X Condition Neurotransmitter Alcoholism Acetylcholine Bipolar Endocannabanoid Anxiety Serotonin 5-HT Depression X 2A Schizophrenia GABA Drug Glutamate ? Addiction Dopamine Eating Disorders Noradrenaline PTSD Other Opiate Address & Analyze Patient Neurochemical Imbalance 2 Drugs/Alcohol affect Neurotransmitter System –to chemically compensate for deficits/excess Alcohol Consumption Record, Substance Use History & Comprehensive Drinker Profile. Verify with Family Members Helpful information regarding understanding patterns of drinking/drug use – Refer to ‘Drug Index’ in book which lists of drugs and their neurochemical/ neurotransmitters agonistic and antagonistic effects. Diagram 2 – Effects of Drug Abuse Example- Cocaine Addiction, Genetically Depressed Patient • Explore findings on Neurotransmitter pubmed.com. How Acetylcholine specific drugs Endocannabanoid [stimulate/inhibit] }Serotonin production of affected neurotransmitters. GABA [slight] • Patient chooses drugs Glutamate D1, D2 Agonist that boost lacking/low Dopamine neurotransmitters. Noradrenaline Opiate Diagram 2 – Effects of Drug Abuse • Example - Cocaine Addiction on Genetically Depressed Patient • How the drug influences original genetic deficiencies • Arrows show if drug influences [stimulates/inhibits] production of affected neurotransmitter. Effect of self-medication. Neurotransmitter Condition X Alcoholism Acetylcholine Bipolar Endocannabanoid Anxiety Serotonin Depression X GABA Schizophrenia [slight] Glutamate Drug Addiction X D1, D2 Agonist Eating Disorders Dopamine PTSD Noradrenaline Other Opiate Diagram 1 & 2 Match-Up Action of Drug –Self Medication produces Desired Effect (Balance) in Diagram 2 cancels out any Deficiencies in Diagram 1. Diagram 2 Diagram 1 Neurotransmitter Acetylcholine Endocannabanoid Serotonin GABA Self-Medication [slight] ? Glutamate } Dopamine D1, D2 Agonist Noradrenaline Opiate Address & Analyze Patient Neurochemical Imbalance 3 Withdrawal/detoxification alters neurotransmitter levels. 1. Pattern parallels/surpasses initial assessment in Genetic Deficiencies. 2. More likely will rebound with Withdrawal/Detox affect. Diagram 3 – Anticipating Effect of Withdrawal on Neurotransmitter Levels • Neurochemical imbalances caused by drugs will lead to withdrawal Effect of withdrawal once cocaine is discontinued. Diagram 3 –Withdrawal • Withdrawal = Brain’s method of up-regulation. • (Returning Brain’s neurochemical balance to original genetic baseline.) • Severe agitation Could signify by negative or minus sign “-” in areas of down arrows. -- Address & Analyze Patient Neurochemical Imbalance 4 Medications balance Neurotransmitter levels. 1. Review medication to block the ‘high’. 2. to lower specific neurotransmitters 3. to raise specific neurotransmitters Diagram 4 – The Treatment Plan After viewing Diagrams 1, 2 & 3; consider how to eliminate craving once the drugs of choice are removed. • Visualize ALL corrective measures. • Show effects of Medications use to correct: 1) Genetic Deficiencies, 2) Drug Abuse, 3) Withdrawal. Diagram 4 –Treatment Diagram All Corrective Measures • Close up –Detail Medication affects to remedy depression & cocaine addiction Neurotransmitter Acetylcholine Endocannabanoid Serotonin Medication – depends on symptoms GABA Glutamate Slowly Dopamine Agonist Noradrenaline Opiate Why Use These Diagrams? • Visualization through diagrams emphasizes which neurotransmitters impact: 1) Drug Use, X 2) Mental Status & Neurotransmitter 3) Neurotransmitter Acetylcholine Endocannabanoid Inadequacies Serotonin 4) Greatly Improve GABA Quality & Outcome Glutamate of Patient TreatmentDopamine 5) Science-Based, Noradrenaline not Intuition Opiate Why Use These Diagrams? • Improve skills in gathering the right Information 1) Genetic Makeup, 2) Desired Drugs Neurotransmitter X 3) Last Use of Drug Acetylcholine 4) Current Feelings Endocannabanoid 5) Level of Craving Serotonin If uncertain, take GABA no action. Instead, Glutamate Gather more Data! Dopamine Noradrenaline Opiate Diagrams – Valuable to Field of Detoxification • Confused? Learn more of neurotransmitter systems • Practice with patients until proficient • Look at drugs in a new way: actions on neurotransmitter sites & chain reaction effects. X Neurotransmitter Acetylcholine Endocannabanoid Serotonin GABA Glutamate Dopamine Noradrenaline Diagram Synopsis 1)Genetic Baseline of Neurochemical Deficiencies – Note the Imbalance! 2)Drugs addicted to & affected Neurotransmitters 3)How Detox alter Neurotransmitter levels 4)Corrective Medications used for a) Safe Withdrawal b) Rids Cravings Neurotransmitter
Load more

Recommended publications
  • The Baseline Structure of the Enteric Nervous System and Its Role in Parkinson’S Disease
    life Review The Baseline Structure of the Enteric Nervous System and Its Role in Parkinson’s Disease Gianfranco Natale 1,2,* , Larisa Ryskalin 1 , Gabriele Morucci 1 , Gloria Lazzeri 1, Alessandro Frati 3,4 and Francesco Fornai 1,4 1 Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy; [email protected] (L.R.); [email protected] (G.M.); [email protected] (G.L.); [email protected] (F.F.) 2 Museum of Human Anatomy “Filippo Civinini”, University of Pisa, 56126 Pisa, Italy 3 Neurosurgery Division, Human Neurosciences Department, Sapienza University of Rome, 00135 Rome, Italy; [email protected] 4 Istituto di Ricovero e Cura a Carattere Scientifico (I.R.C.C.S.) Neuromed, 86077 Pozzilli, Italy * Correspondence: [email protected] Abstract: The gastrointestinal (GI) tract is provided with a peculiar nervous network, known as the enteric nervous system (ENS), which is dedicated to the fine control of digestive functions. This forms a complex network, which includes several types of neurons, as well as glial cells. Despite extensive studies, a comprehensive classification of these neurons is still lacking. The complexity of ENS is magnified by a multiple control of the central nervous system, and bidirectional communication between various central nervous areas and the gut occurs. This lends substance to the complexity of the microbiota–gut–brain axis, which represents the network governing homeostasis through nervous, endocrine, immune, and metabolic pathways. The present manuscript is dedicated to Citation: Natale, G.; Ryskalin, L.; identifying various neuronal cytotypes belonging to ENS in baseline conditions.
    [Show full text]
  • Protocol for a Randomised Controlled Trial: Efficacy of Donepezil Against
    BMJ Open: first published as 10.1136/bmjopen-2013-003533 on 25 September 2013. Downloaded from Open Access Protocol Protocol for a randomised controlled trial: efficacy of donepezil against psychosis in Parkinson’s disease (EDAP) Hideyuki Sawada, Tomoko Oeda To cite: Sawada H, Oeda T. ABSTRACT ARTICLE SUMMARY Protocol for a randomised Introduction: Psychosis, including hallucinations and controlled trial: efficacy of delusions, is one of the important non-motor problems donepezil against psychosis Strengths and limitations of this study in patients with Parkinson’s disease (PD) and is in Parkinson’s disease ▪ In previous randomised controlled trials for (EDAP). BMJ Open 2013;3: possibly associated with cholinergic neuronal psychosis the efficacy was investigated in patients e003533. doi:10.1136/ degeneration. The EDAP (Efficacy of Donepezil against who presented with psychosis and the primary bmjopen-2013-003533 Psychosis in PD) study will evaluate the efficacy of endpoint was improvement of psychotic symp- donepezil, a brain acetylcholine esterase inhibitor, for toms. By comparison, this study is designed to prevention of psychosis in PD. ▸ Prepublication history for evaluate the prophylactic effect in patients this paper is available online. Methods and analysis: Psychosis is assessed every without current psychosis. Because psychosis To view these files please 4 weeks using the Parkinson Psychosis Questionnaire may be overlooked and underestimated it is visit the journal online (PPQ) and patients with PD whose PPQ-B score assessed using a questionnaire, Parkinson (http://dx.doi.org/10.1136/ (hallucinations) and PPQ-C score (delusions) have Psychosis Questionnaire (PPQ) every 4 weeks. bmjopen-2013-003533). been zero for 8 weeks before enrolment are ▪ The strength of this study is its prospective randomised to two arms: patients receiving donepezil design using the preset definition of psychosis Received 3 July 2013 hydrochloride or patients receiving placebo.
    [Show full text]
  • Nicotine and Neurotransmitters
    Module 2 —Legal Doesn’t Mean Harmless Overview Overview Summary This module focuses on how two drugs, nicotine and alcohol, change the functioning of the brain and body. Both drugs are widely used in the community, and for adults, using them is legal. Nonetheless, both alcohol and nicotine can have a strong impact on the functioning of the brain. Each can cause a number of negative effects on the body and brain, ranging from mild symptoms to addiction. The goal of this module is to help students understand that, although nicotine and alcohol are legal for adults, they are not harmless substances. Students will learn about how nicotine and alcohol change or disrupt the process of neurotransmission. Students will explore information on the short- and long- term effects of these two drugs, and also learn why these drugs are illegal for children and teens. Through the media, students are exposed to a great deal of information about alcohol and tobacco, much of which is misleading or scientifically inaccurate. This module will provide information on what researchers have learned about how nicotine and alcohol change the brain, and the resulting implications for safety and health. Learning Objectives At the end of this module: • Students can explain how nicotine disrupts neurotransmission. • Students can explain how alcohol use may harm the brain and the body. • Students understand how alcohol can intensify the effect of other drugs. • Students can define addiction and understand its basis in the brain. • Students draw conclusions about why our society regulates the use of nicotine and alcohol for young people.
    [Show full text]
  • Oxytocin Effects in Mothers and Infants During Breastfeeding
    © 2013 SNL All rights reserved REVIEW Oxytocin effects in mothers and infants during breastfeeding Oxytocin integrates the function of several body systems and exerts many effects in mothers and infants during breastfeeding. This article explains the pathways of oxytocin release and reviews how oxytocin can affect behaviour due to its parallel release into the blood circulation and the brain. Oxytocin levels are higher in the infant than in the mother and these levels are affected by mode of birth. The importance of skin-to-skin contact and its association with breastfeeding and mother-infant bonding is discussed. Kerstin Uvnäs Moberg Oxytocin – a system activator increased function of inhibitory alpha-2 3 MD, PhD xytocin, a small peptide of just nine adrenoceptors . Professor of Physiology amino acids, is normally associated The regulation of the release of oxytocin Swedish University of Agriculture O with labour and the milk ejection reflex. is complex and can be affected by different [email protected] However, oxytocin is not only a hormone types of sensory inputs, by hormones such Danielle K. Prime but also a neurotransmitter and a as oestrogen and even by the oxytocin 1,2 molecule itself. This article will focus on PhD paracrine substance in the brain . During Breastfeeding Research Associate breastfeeding it is released into the brain of four major sensory input nervous Medela AG, Baar, Switzerland both mother and infant where it induces a pathways (FIGURES 2 and 3) activated by: great variety of functional responses. 1. Sucking of the mother’s nipple, in which Through three different release pathways the sensory nerves originate in the (FIGURE 1), oxytocin functions rather like a breast.
    [Show full text]
  • Neurotransmitter Actions
    Central University of South Bihar Panchanpur, Gaya, India E-Learning Resources Department of Biotechnology NB: These materials are taken/borrowed/modified/compiled from various resources like research articles and freely available internet websites, and are meant to be used solely for the teaching purpose in a public university, and for serving the needs of specified educational programmes. Dr. Jawaid Ahsan Assistant Professor Department of Biotechnology Central University of South Bihar (CUSB) Course Code: MSBTN2003E04 Course Name: Neuroscience Neurotransmitter Actions • Excitatory Action: – A neurotransmitter that puts a neuron closer to an action potential (facilitation) or causes an action potential • Inhibitory Action: – A neurotransmitter that moves a neuron further away from an action potential • Response of neuron: – Responds according to the sum of all the neurotransmitters received at one time Neurotransmitters • Acetylcholine • Monoamines – modified amino acids • Amino acids • Neuropeptides- short chains of amino acids • Depression: – Caused by the imbalances of neurotransmitters • Many drugs imitate neurotransmitters – Ex: Prozac, zoloft, alcohol, drugs, tobacco Release of Neurotransmitters • When an action potential reaches the end of an axon, Ca+ channels in the neuron open • Causes Ca+ to rush in – Cause the synaptic vesicles to fuse with the cell membrane – Release the neurotransmitters into the synaptic cleft • After binding, neurotransmitters will either: – Be destroyed in the synaptic cleft OR – Taken back in to surrounding neurons (reuptake) Excitable cells: Definition: Refers to the ability of some cells to be electrically excited resulting in the generation of action potentials. Neurons, muscle cells (skeletal, cardiac, and smooth), and some endocrine cells (e.g., insulin- releasing pancreatic β cells) are excitable cells.
    [Show full text]
  • Neurochemical Mechanisms Underlying Alcohol Withdrawal
    Neurochemical Mechanisms Underlying Alcohol Withdrawal John Littleton, MD, Ph.D. More than 50 years ago, C.K. Himmelsbach first suggested that physiological mechanisms responsible for maintaining a stable state of equilibrium (i.e., homeostasis) in the patient’s body and brain are responsible for drug tolerance and the drug withdrawal syndrome. In the latter case, he suggested that the absence of the drug leaves these same homeostatic mechanisms exposed, leading to the withdrawal syndrome. This theory provides the framework for a majority of neurochemical investigations of the adaptations that occur in alcohol dependence and how these adaptations may precipitate withdrawal. This article examines the Himmelsbach theory and its application to alcohol withdrawal; reviews the animal models being used to study withdrawal; and looks at the postulated neuroadaptations in three systems—the gamma-aminobutyric acid (GABA) neurotransmitter system, the glutamate neurotransmitter system, and the calcium channel system that regulates various processes inside neurons. The role of these neuroadaptations in withdrawal and the clinical implications of this research also are considered. KEY WORDS: AOD withdrawal syndrome; neurochemistry; biochemical mechanism; AOD tolerance; brain; homeostasis; biological AOD dependence; biological AOD use; disorder theory; biological adaptation; animal model; GABA receptors; glutamate receptors; calcium channel; proteins; detoxification; brain damage; disease severity; AODD (alcohol and other drug dependence) relapse; literature review uring the past 25 years research- science models used to study with- of the reasons why advances in basic ers have made rapid progress drawal neurochemistry as well as a research have not yet been translated Din understanding the chemi- reluctance on the part of clinicians to into therapeutic gains and suggests cal activities that occur in the nervous consider new treatments.
    [Show full text]
  • Two Types of Muscarinic Response to Acetylcholine in Mammalian Cortical Neurons (Clngulate/M Current/Cholinergic/Pirenzepine) DAVID A
    Proc. Nail. Acad. Sci. USA Vol. 82, pp. 6344-6348, September 1985 Neurobiology Two types of muscarinic response to acetylcholine in mammalian cortical neurons (clngulate/M current/cholinergic/pirenzepine) DAVID A. MCCORMICK AND DAVID A. PRINCE Department of Neurology, Room C338, Stanford University School of Medicine, Stanford, CA 94305 Communicated by Richard F. Thompson, May 22, 1985 ABSTRACT Applications of acetylcholine (AcCho) to py- The cerebral cortex contains nicotinic as well as several ramidal cells of guinea pig cingulate cortical slices maintained subtypes of muscarinic AcCho receptors (20-23). Previous in vitro result in a short latency inhibition, followed by a reports suggest that cholinergic slow excitation is mediated prolonged increase in excitability. Cholinergic inhibition is by receptors possessing muscarinic characteristics, while mediated through the rapid excitation of interneurons that cholinergic inhibition may be due to activation of receptors utilize the inhibitory neurotransmitter y-aminobutyric acid that have both nicotinic and muscarinic properties (5, 24). (GABA). This rapid excitation of interneurons is. associated The recent characterization of receptor antagonists (e.g., with a membrane depolarization and a decrease in neuronal pirenzepine) and agonists (e.g., pilocarpine) that are relative- input resistance. In contrast, AcCho-induced excitation of ly specific for subtypes ofmuscarinic receptors (21, 22) raises pyramidal cells is due to a direct action that produces a the question of whether different types of cholinergic re- voltage-dependent increase in input resistance. In the experi- sponses demonstrated physiologically within the central ments reported here, we investigated the possibility that these nervous system might be due to activation of different two responses are mediated by different subclasses of cholin- subclasses of muscarinic receptors, as appears to be the case ergic receptors.
    [Show full text]
  • Therapeutic Effect of Agmatine on Neurological Disease: Focus on Ion Channels and Receptors
    Neurochemical Research (2019) 44:735–750 https://doi.org/10.1007/s11064-018-02712-1 REVIEW PAPER Therapeutic Effect of Agmatine on Neurological Disease: Focus on Ion Channels and Receptors Sumit Barua1 · Jong Youl Kim1 · Jae Young Kim1 · Jae Hwan Kim4 · Jong Eun Lee1,2,3 Received: 15 October 2018 / Revised: 19 December 2018 / Accepted: 24 December 2018 / Published online: 4 January 2019 © Springer Science+Business Media, LLC, part of Springer Nature 2019 Abstract The central nervous system (CNS) is the most injury-prone part of the mammalian body. Any acute or chronic, central or peripheral neurological disorder is related to abnormal biochemical and electrical signals in the brain cells. As a result, ion channels and receptors that are abundant in the nervous system and control the electrical and biochemical environment of the CNS play a vital role in neurological disease. The N-methyl-D-aspartate receptor, 2-amino-3-(5-methyl-3-oxo-1,2-oxazol-4-yl) propanoic acid receptor, kainate receptor, acetylcholine receptor, serotonin receptor, α2-adrenoreceptor, and acid-sensing ion channels are among the major channels and receptors known to be key components of pathophysiological events in the CNS. The primary amine agmatine, a neuromodulator synthesized in the brain by decarboxylation of L-arginine, can regu- late ion channel cascades and receptors that are related to the major CNS disorders. In our previous studies, we established that agmatine was related to the regulation of cell differentiation, nitric oxide synthesis, and murine brain endothelial cell migration, relief of chronic pain, cerebral edema, and apoptotic cell death in experimental CNS disorders.
    [Show full text]
  • Agmatine and Agmatine Analogs in the Treatment of Epilepsy, Seizure, and Electroconvulsive Disorders Peter A
    University of Kentucky UKnowledge Pharmaceutical Sciences Faculty Patents Pharmaceutical Sciences 10-19-2010 Agmatine and Agmatine Analogs in the Treatment of Epilepsy, Seizure, and Electroconvulsive Disorders Peter A. Crooks University of Kentucky, [email protected] Aimee K. Bence David R. Worthen Right click to open a feedback form in a new tab to let us know how this document benefits oy u. Follow this and additional works at: https://uknowledge.uky.edu/ps_patents Part of the Pharmacy and Pharmaceutical Sciences Commons Recommended Citation Crooks, Peter A.; Bence, Aimee K.; and Worthen, David R., "Agmatine and Agmatine Analogs in the Treatment of Epilepsy, Seizure, and Electroconvulsive Disorders" (2010). Pharmaceutical Sciences Faculty Patents. 47. https://uknowledge.uky.edu/ps_patents/47 This Patent is brought to you for free and open access by the Pharmaceutical Sciences at UKnowledge. It has been accepted for inclusion in Pharmaceutical Sciences Faculty Patents by an authorized administrator of UKnowledge. For more information, please contact [email protected]. US007816407B2 (12) United States Patent (10) Patent N0.: US 7,816,407 B2 Crooks et al. (45) Date of Patent: Oct. 19, 2010 (54) AGMATINE AND AGMATINE ANALOGS IN The Merck Index, Merck Research Laboratories Division of Merck & THE TREATMENT OF EPILEPSY, SEIZURE, Co., Inc. 1996, p. 35. AND ELECTROCONVULSIVE DISORDERS James O. McNamara, “Drugs Effective in Therapy of the Epilepsies”, Goodman & Gilman’s The Pharmacological Basis of Therapeutics, (75) Inventors: Peter A. Crooks, Lexington, KY (US); Ninth Edition, Chapter 20, pp. 461-486, 1996. Aimee K. Bence, Lexington, KY (US); I. Tayfun Uzbay et al., “Effects of agmatine on ethanol Withdrawal David R.
    [Show full text]
  • Redalyc.Neurobiological Alterations in Alcohol Addiction: a Review
    Adicciones ISSN: 0214-4840 [email protected] Sociedad Científica Española de Estudios sobre el Alcohol, el Alcoholismo y las otras Toxicomanías España Erdozain, Amaia M.; Callado, Luis F. Neurobiological alterations in alcohol addiction: a review Adicciones, vol. 26, núm. 4, octubre-diciembre, 2014, pp. 360-370 Sociedad Científica Española de Estudios sobre el Alcohol, el Alcoholismo y las otras Toxicomanías Palma de Mallorca, España Available in: http://www.redalyc.org/articulo.oa?id=289132934009 How to cite Complete issue Scientific Information System More information about this article Network of Scientific Journals from Latin America, the Caribbean, Spain and Portugal Journal's homepage in redalyc.org Non-profit academic project, developed under the open access initiative revisión adicciones vol. 26, nº 3 · 2014 Neurobiological alterations in alcohol addiction: a review Alteraciones neurobiológicas en el alcoholismo: revisión Amaia M. Erdozain*,*** and Luis F. Callado*,** *Department of Pharmacology, University of the Basque Country UPV/EHU, Leioa, Bizkaia, Spain and Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain. **Biocruces Health Research Institute, Bizkaia, Spain. ***Neuroscience Paris Seine, Université Pierre et Marie Curie, Paris, France Resumen Abstract Todavía se desconoce el mecanismo exacto mediante el cual el etanol The exact mechanism by which ethanol exerts its effects on the brain produce sus efectos en el cerebro. Sin embargo, hoy en día se sabe is still unknown. However, nowadays it is well known that ethanol que el etanol interactúa con proteínas específicas de la membrana interacts with specific neuronal membrane proteins involved in neuronal, implicadas en la transmisión de señales, produciendo así signal transmission, resulting in changes in neural activity.
    [Show full text]
  • Oxytocinergic-System-A-Proposal.Pdf
    Opinion Article iMedPub Journals ACTA PSYCHOPATHOLOGICA 2018 www.imedpub.com ISSN 2469-6676 Vol.4 No.3:14 DOI: 10.4172/2469-6676.100170 Oxytocinergic System: A Proposal João Paulo Correia Lima* and Avelino Luiz Rodrigues Received: April 17, 2018; Accepted: May 07, 2018; Published: May 18, 2018 Department of Clinical Psychology and Nucleus of Neuroscience and Behavior, Institute of Psychology, University of Sao Introduction Paulo, Brazil Since 1910, when Ott and Scott [1] published their discovers about the oxytocin participation in milk ejection, the comprehension *Corresponding author: about function and role of oxytocin in several physiological João Paulo Correia Lima functions didn’t stop enlarging and growing. In birth, through his action over uterus contractions, in uterus contractions in [email protected] women’s orgasm and men’s erection [2,3], for instance. However, this approach always considers its peripheral effects. After this, Psychologist for Neuroscience and Behavior, some oxytocin effects had been reported to have actions over Institute of Psychology, University of Sao behavioural traits, like we can see in publishings of Pedersen and Paulo, Brazil. Prange [4] and Winslow and co-workers [5], reporting the oxytocin actions over, respectively, maternal behaviour and pair bonding. Tel: +55-11-32852420; +55-11-983439754 Since then, the increasing data about the oxytocin’s function in behaviour and its central action can’t be ignored. In this short proposal, we’ll consider the opportunity or utility of thinking Citation about oxytocin as a system, instead of a single neurotransmitter. : Lima JPC, Rodrigues AL (2018) Oxytocinergic System: A Proposal. Acta Neurotransmitter or Hormone: Central Psychopathol Vol.4 No.3:14 and Peripheral Actions of Oxytocin Once a molecule could have his function defined through the way death, passive avoidance).
    [Show full text]
  • The Efficacy and Safety of Six-Weeks of Pre-Workout Supplementation in Resistance Trained Rats
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by College of William & Mary: W&M Publish W&M ScholarWorks Undergraduate Honors Theses Theses, Dissertations, & Master Projects 4-2017 The Efficacy and Safety of Six-Weeks of Pre-Workout Supplementation in Resistance Trained Rats Justin P. Canakis College of William and Mary Follow this and additional works at: https://scholarworks.wm.edu/honorstheses Part of the Animal Sciences Commons, Exercise Science Commons, Laboratory and Basic Science Research Commons, and the Other Nutrition Commons Recommended Citation Canakis, Justin P., "The Efficacy and Safety of Six-Weeks of Pre-Workout Supplementation in Resistance Trained Rats" (2017). Undergraduate Honors Theses. Paper 1128. https://scholarworks.wm.edu/honorstheses/1128 This Honors Thesis is brought to you for free and open access by the Theses, Dissertations, & Master Projects at W&M ScholarWorks. It has been accepted for inclusion in Undergraduate Honors Theses by an authorized administrator of W&M ScholarWorks. For more information, please contact [email protected]. 1 2 Title Page……………………………………………………………………………………...…..1 Abstract…………………………………………………………………………………………....5 Acknowledgement……………………………………………………………………….………..6 Background.………………………………………………………………………..……………...7 DSEHA and its Effect on the VMS Industry………………...……………………………7 History of Adverse Side Effects from Pre-Workout Supplements ………….……………8 Ingredient Analysis ………………………………………..……………….……………..……....9 2.5g Beta-Alanine…………………………..……………………………………………..9
    [Show full text]